Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?

Area of Science:

• Pulmonology
• Rheumatology
• Critical Care Medicine

Background:

• Interstitial pneumonia with autoimmune features (IPAF) is a recently identified syndrome involving interstitial lung disease and autoantibodies.
• IPAF is diagnosed in the absence of a specific connective tissue disease or other known causes for lung disease.
• This study focuses on critically ill patients diagnosed with IPAF.

Purpose of the Study:

• To describe the clinical presentation, management, and outcomes of critically ill patients with IPAF.
• To compare the survival rates of IPAF patients with acute respiratory distress syndrome (ARDS) to other ARDS patient groups.

Main Methods:

• Retrospective review of seven critically ill patients meeting IPAF criteria.
• Comparison of IPAF patients with ARDS patients who had known risk factors (n=78) and those without (n=8).
• Analysis of baseline characteristics, diagnostic workup, and clinical outcomes.

Main Results:

• Seven IPAF patients were admitted to the ICU with ARDS; five (71%) survived.
• IPAF patient survival was comparable to ARDS patients with known risk factors (71%) but higher than those without risk factors (38%).
• All IPAF patients required prolonged mechanical ventilation, and most received advanced respiratory support; immunosuppressive therapy was administered to all.

Conclusions:

• This is the first cohort study of critical IPAF patients with ARDS.
• IPAF should be considered in critically ill patients with unexplained interstitial lung disease.
• Despite challenging management and high support needs, IPAF patients with ARDS have favorable survival outcomes.